The Pharmacokinetics of 4% Lidocaine Gel When Applied Topically to the Breasts
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the hypothesis that one-time application of 4% lidocaine
gel (TOPICAINE) on the skin of the breasts and chest wall as recommended for pre-medication
to reduce discomfort during screening mammography does not result in adverse effects,
electrocardiogram (EKG) changes, or systemically toxic plasma concentration of lidocaine or
its principal metabolite, monoethylglycinexylidide (MEGX).
Phase:
Phase 4
Details
Lead Sponsor:
Mountain States Tumor and Medical Research Institute